Navigation Links
New Data Confirm That Use of Levemir Can Limit Weight Gain

lished that even modest weight loss is associated with improvement in blood glucose control, insulin sensitivity and the cardiovascular risk profile.(4-9)

The unique weight benefit of Levemir® has been reported in every single clinical trial published where it has been compared to other basal insulins.(10-23) Collectively these trials provide data representing more than 4,000 patients. In two recently published randomised clinical trials that investigated insulin initiation in type 2 diabetes, mean weight gain was reduced by more than 50% when comparing Levemir® to equivalent regimens of NPH insulin.(10,11) Furthermore, the relative weight benefit of Levemir® was shown to increase with increasing body mass index (BMI).(11) Thus, the weight advantage of Levemir® tended to be more pronounced in more overweight patients.

For further information please contact

Michael Laub

Tel: (+45) 4442 1960

About Levemir®

Levemir® is a long-acting modern insulin (insulin analogue) that covers the body’s basal insulin needs. Levemir® is released gradually from the injection site into the circulation. Compared to conventional long-acting insulins such as NPH insulin, Levemir® causes less fluctuation in blood glucose levels across the day and has greater predictability, ie a blood glucose lowering effect that is consistent from one injection to another. A single daily dose of Levemir® will provide a duration of action up to 24 hours.(24) The dose should be taken in the evening, at dinner or before bedtime. Injections can easily be managed with the simple and discreet FlexPen®, a prefilled insulin pen.(26,27)

About Novo Nordisk

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addit
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
4. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
5. New Data Confirms Significant Improvement of Disease Signs and Symptoms in Patients with Rheumatoid Arthritis
6. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
7. New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients
8. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
9. Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to Treating Inflammatory Diseases
10. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
11. Efficacy and Safety Profile of Basileas Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Data Confirm That Use Levemir Can Limit Weight Gain
(Date:7/30/2015)... July 30, 2015 ... report with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... Insight: Biosensors Market Development and Demand Forecast ... http://photos.prnewswire.com/prnh/20150727/756778 ) Explore more about ...
(Date:7/30/2015)... 2015 Vermillion, Inc. (VRML), a ... announced today it will report its second ... close on Thursday, August 13, 2015, followed ... at 4:30pm Eastern.Conference Call and Webcast:  ... Pacific  Domestic: , 888-430-8691International: ...
(Date:7/30/2015)... , July 30, 2015 What ... ? Which areas are going to grow at the ... you potential revenues to 2025, assessing data, trends, opportunities ... provides 176 tables, charts, and graphs. Discover the ... market prospects. Our new study lets you assess forecasted ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced ... private company that holds certain rights and know-how to poloxamer-based ... the target company. About the ... target company contemplate an all-stock acquisition by merger. Other than ...
... 2011 Amarin Corporation plc (Nasdaq: AMRN ... focus on cardiovascular disease, today announced that, in connection ... Depositary Shares ("ADSs"), the underwriters of the offering have ... an aggregate of 1,800,000 additional ADSs to cover over-allotments. ...
Cached Medicine Technology:ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 2ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 3ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 4ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 5Amarin Announces Underwriters' Exercise of Over-Allotment Option 2Amarin Announces Underwriters' Exercise of Over-Allotment Option 3Amarin Announces Underwriters' Exercise of Over-Allotment Option 4
(Date:7/31/2015)... ... July 31, 2015 , ... ... and the growing number of individuals who remain undiagnosed, treatment options for patients ... shy away from traditional CPAP therapy due to its overall lack of comfort ...
(Date:7/30/2015)... ... July 30, 2015 , ... Dale Sky Jones, Executive Chancellor of ... at the International Cannabis Professionals Expo held at the Caribe Royal All Suites Hotel ... Cannabis Professionals Expo is the largest medical cannabis expo in the country and ...
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... The Venetian on Grace Bay in the ... Guests who stay at the Venetian will save 40% on their stay while enjoying some ... always quiet in the Turks & Caicos, providing a chance to reconnect with loved ones ...
(Date:7/30/2015)... Ferry, New York (PRWEB) , ... July 31, 2015 , ... ... Barack Obama’s call to action by asking community members to contribute to the College’s ... on, “Helping more of our young people stay on track. Providing the support they ...
(Date:7/30/2015)... ... July 30, 2015 , ... As more hospitals across ... of recruiting patients becomes a serious challenge. Because of growing competition, it is ... within the local community. , The team at Wound Care Advantage ...
Breaking Medicine News(10 mins):Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4
... System scheduled to start this month.BERKELEY HEIGHTS, N.J., ... formed by Authentidate Holding Corp. (Nasdaq: ... ECSL) to provide remote patient monitoring telehealth systems ... chronic conditions announced today that its remote patient ...
... Four conferences scheduled for Wayne ... Adult Well-Being Services will host four conferences in ... vital information and critical support to persons caring for ... on issues ranging from legal and financial concerns to ...
... a fully human monoclonal antibody that inhibits the activity ... to reduce pancreatic cancer cells in early testing, according ... a journal of the American Association for Cancer Research. ... and less than 4 percent of the 200,000 patients ...
... Medical device industry leaders, lawmakers, and government ... of the Medical Device Manufacturers Association (MDMA) June ... Washington, D.C. (Logo: ... bring together executives from innovative entrepreneurial medical technology ...
... "Making the Stroke Connection" will take place on Friday, May ... 12 p.m. Activities include a stroke survivor/caregiver forum, a CME/CEU ... an awards celebration lunch from 12:30 2 p.m., hosted ... Milton Resident Margaret Kelly-Hayes, EdD, RN, FAAN, FAHA, CRRN, is ...
... Mass., April 14 Intrinsic Therapeutics, Inc. announced today ... Barricaid(R) anular prosthesis for use in reconstructing soft tissues ... approval to distribute the Barricaid throughout the European Union ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090414/NE98588LOGO ...
Cached Medicine News:Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 2Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 3Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 4Health News:ExpressMD(TM) Solutions' Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA 5Health News:Adult Well-Being Services Offers Valuable Resources for Caregivers 2Health News:Adult Well-Being Services Offers Valuable Resources for Caregivers 3Health News:AHRQ Director Carolyn Clancy and Dr. Mark McClellan to Address Device Executives 2009 MDMA Annual Meeting 2Health News:Milton resident receives the Helen B. Spaulding Community Conscience Award 2Health News:Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: